Product Information
HYDROCODONE ER 20 MG TABLET is a generic product labeled by Alvogen Inc., priced at $8.0192 per EA under NDC 47781039260. Its NADAC has been published 69 times since Feb 19, 2025.
FDA first approved this application on Mar 1, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Alvogen Inc.NDC
47781039260
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208269FDA Approved
3/1/2021
TE Code
AB
On Market Since
3/3/2021
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE ER 20 MG TABLET has been published 69 times since Feb 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0192 per EA |
|---|---|
| All-time high | $8.0192 (Jun 10, 2026) |
| All-time low | $8.0138 (Mar 19, 2025) |
| 52-week high | $8.0192 |
| 52-week low | $8.0192 |
| Median price | $8.0192 |
| Average price | $8.0183 |
| Largest weekly change | -0.1% (Mar 19, 2025) |
| Weeks tracked | 69 |
| Tracking since | Feb 19, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jun 10, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocodone Bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE ER 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE ER 20 MG TABLET, manufactured by Alvogen Inc., is $8.0192 per EA (NDC 47781039260), effective Jun 10, 2026.
How has the price of HYDROCODONE ER 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE ER 20 MG TABLET has held within roughly two percent of its current level. It has been tracked across 69 weekly CMS publications since Feb 19, 2025.
What are the highest and lowest recorded NADAC prices for HYDROCODONE ER 20 MG TABLET?
Since Feb 19, 2025, the NADAC for HYDROCODONE ER 20 MG TABLET has ranged from a low of $8.0138 (Mar 19, 2025) to a high of $8.0192 (Jun 10, 2026), with a median of $8.0192 per EA.
Are there cheaper alternatives to HYDROCODONE ER 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE ER 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE ER 20 MG TABLET?
HYDROCODONE ER 20 MG TABLET (NDC 47781039260) is labeled by Alvogen Inc., and CMS classifies it as a generic product.